ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly cash paid for share repurchases ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Cash Flows & Shareholders' Equity Note
Latest, FY2025
4,108
Period ended Dec 31, 2025
Change on a year earlier
+64.3%
2,500 in FY2024
History
16 years
Since FY2010
Sources
12
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash paid for share repurchases ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,108 | +64.3% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 2,500 | +233.3% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 750 | -50.0% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | 1,500 | +20.0% | Form 10-K (filed 2025-02-19) ↗ |
| FY2021 | Dec 31, 2021 | 1,250 | +150.0% | Form 10-K (filed 2024-02-21) ↗ |
| FY2020 | Dec 31, 2020 | 500 | -88.6% | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 4,400 | +6.0% | Form 10-K (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 4,151 | +1,284.5% | Form 10-K (filed 2021-02-17) ↗ |
| FY2017 | Dec 31, 2017 | 300 | -50.0% | Form 10-K (filed 2020-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 600 | -19.9% | Form 10-K (filed 2019-02-19) ↗ |
| FY2015 | Dec 31, 2015 | 750 | -6.3% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 800 | -52.9% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 1,698 | +135.5% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 721 | – | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | -0 | – | Form 10-K (filed 2013-02-21) ↗ |
| FY2010 | Dec 31, 2010 | -0 | – | Form 10-K (filed 2013-02-21) ↗ |
Breakdown
What makes up cash paid for share repurchases ($m)
Cite this data
StockData. (2026). Eli Lilly Cash paid for share repurchases ($M) ($M), annual FY2010–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/buyback_cash_paid
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.